scholarly article | Q13442814 |
P356 | DOI | 10.1080/00365521.2017.1305123 |
P698 | PubMed publication ID | 28346031 |
P50 | author | Odd Helge Gilja | Q56655099 |
Trygve Hausken | Q64051500 | ||
Jan Gunnar Hatlebakk | Q64140834 | ||
Magdy El-Salhy | Q87422049 | ||
P2093 | author name string | Tanisa Patcharatrakul | |
Sutep Gonlachanvit | |||
P2860 | cites work | Is chromogranin a prohormone? | Q58966885 |
Neuropeptides and inflammatory bowel disease | Q39940321 | ||
The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors | Q41027346 | ||
Chromogranin A cell density as a diagnostic marker for lymphocytic colitis | Q42350284 | ||
Prevalence of irritable bowel syndrome in Hong Kong | Q43359175 | ||
Functional bowel symptoms in a general Dutch population and associations with common stimulants | Q43662427 | ||
Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria | Q43763654 | ||
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population | Q44037464 | ||
Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire | Q44056837 | ||
Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior | Q44592732 | ||
Monocyte migration: a novel effect and signaling pathways of catestatin | Q46138950 | ||
Health-care-seeking behaviors related to bowel complaints. Hispanics versus non-Hispanic whites | Q47188088 | ||
Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. | Q50995784 | ||
Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. | Q51803884 | ||
Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? | Q51971888 | ||
The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD) | Q26782555 | ||
The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour | Q27002574 | ||
The chromogranin-secretogranin family | Q28185052 | ||
Functional bowel disorders | Q29620328 | ||
Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome | Q33852241 | ||
Are rice and spicy diet good for functional gastrointestinal disorders? | Q33890531 | ||
The Current Prevalence of Irritable Bowel Syndrome in Asia | Q34298271 | ||
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact | Q34353536 | ||
Prevalence and management of abdominal cramping and pain: a multinational survey | Q34547643 | ||
Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed | Q34612294 | ||
Guidelines on the irritable bowel syndrome: mechanisms and practical management. | Q34626602 | ||
Recent developments in the pathophysiology of irritable bowel syndrome | Q35689193 | ||
The gut microbiota and irritable bowel syndrome: friend or foe? | Q35942511 | ||
Irritable bowel syndrome in developing countries--a disorder of civilization or colonization? | Q36139386 | ||
High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis | Q36395349 | ||
Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker | Q37779812 | ||
Diffuse endocrine system, neuroendocrine tumors and immunity: what's new? | Q37976162 | ||
Irritable bowel syndrome: the role of gut neuroendocrine peptides | Q38015086 | ||
High resolution colonic manometry--what have we learnt?--A review of the literature 2012. | Q38109566 | ||
Is irritable bowel syndrome an organic disorder? | Q38191561 | ||
Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment | Q38192048 | ||
The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome | Q39031805 | ||
A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling | Q39685480 | ||
Epidemiological features of irritable bowel syndrome in a Turkish urban society | Q39688027 | ||
A population-based study of irritable bowel syndrome in a non-Western population | Q39847065 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6-7 | |
P304 | page(s) | 691-697 | |
P577 | publication date | 2017-03-27 | |
P1433 | published in | Scandinavian Journal of Gastroenterology | Q7429960 |
P1476 | title | Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome | |
P478 | volume | 52 |
Q99567385 | Density of Musashi‑1‑positive stem cells in the stomach of patients with irritable bowel syndrome |
Q92503461 | Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones |
Q48156442 | Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome |
Q57291642 | Evidence of increased fecal granins in children with irritable bowel syndrome and correlates with symptoms |
Q91963317 | Nutritional Management of Gastrointestinal Diseases and Disorders |
Q92628470 | Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting |
Q92053503 | Second Asian Consensus on Irritable Bowel Syndrome |